We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
+$1.27B
Cap. Flow %
1.11%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.51%
3 Healthcare 5.77%
4 Financials 5.47%
5 Communication Services 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SILK
901
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$18.5M 0.02%
1,503,752
+1,362,939
+968% +$12.8M
APA icon
902
PUT
APA Corp
APA
$15.1B
$18.3M 0.02%
510,700
+4,400
+0.9% +$166K
ROP icon
903
CALL
Roper Technologies
ROP
$41.1B
$18.3M 0.02%
+33,600
New +$17.3M
APH icon
904
Amphenol
APH
$192B
$18.3M 0.02%
369,310
-418,160
-53% -$18.5M
MOG.A icon
905
Moog Inc Class A
MOG.A
$12B
$18.3M 0.02%
126,427
+3,883
+3% +$502K
ALNY icon
906
Alnylam Pharmaceuticals
ALNY
$31.6B
$18.3M 0.02%
95,544
-108,548
-53% -$18.5M
EW icon
907
Edwards Lifesciences
EW
$52.2B
$18.3M 0.02%
239,789
-183,440
-43% -$12.8M
CROX icon
908
PUT
Crocs
CROX
$6.03B
$18.3M 0.02%
195,700
-1,600
-0.8% -$148K
SAVE
909
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
$18.2M 0.02%
1,110,000
+1,080,000
+3,600% +$15.5M
GCO icon
910
Genesco
GCO
$390M
$18.2M 0.02%
516,482
-11,360
-2% -$349K
KRNT icon
911
Kornit Digital
KRNT
$708M
$18.2M 0.02%
948,731
-41,878
-4% -$726K
KHC icon
912
CALL
Kraft Heinz
KHC
$30.4B
$18.2M 0.02%
490,900
-108,900
-18% -$3.7M
DISH
913
DELISTED
DISH Network Corp.
DISH
$18.1M 0.02%
3,140,019
+2,138,912
+214% +$9.6M
AMGN icon
914
PUT
Amgen
AMGN
$240B
$18M 0.02%
62,500
+20,000
+47% +$5.45M
EQC
915
DELISTED
Equity Commonwealth
EQC
$18M 0.02%
935,938
+115,660
+14% +$2.19M
IART icon
916
Integra LifeSciences
IART
$1.3B
$17.9M 0.02%
411,857
-35,733
-8% -$1.41M
CARR icon
917
CALL
Carrier Global
CARR
$49.4B
$17.9M 0.02%
312,200
-26,100
-8% -$1.38M
BNY
918
Bank of New York Mellon
BNY
$110B
$17.9M 0.02%
344,588
-314,157
-48% -$14.5M
OPLN
919
Openlane
OPLN
$4.16B
$17.9M 0.02%
1,210,740
+137,877
+13% +$2M
DNOW icon
920
DNOW Inc
DNOW
$2.8B
$17.9M 0.02%
1,582,875
+8,074
+0.5% +$88.5K
SCHW
921
Charles Schwab
SCHW
$197B
$17.9M 0.02%
260,277
-3,299,267
-93% -$191M
SOFI icon
922
SoFi Technologies
SOFI
$23.6B
$17.8M 0.02%
1,793,039
-546,911
-23% -$4.35M
PFGC icon
923
Performance Food Group
PFGC
$16.6B
$17.8M 0.02%
257,936
+206,151
+398% +$12.7M
SNOW icon
924
PUT
Snowflake
SNOW
$112B
$17.8M 0.02%
89,500
-74,100
-45% -$12.5M
FNV icon
925
Franco-Nevada
FNV
$52.1B
$17.8M 0.02%
160,430
+86,827
+118% +$10.6M

Similar funds

David Shaw's Q4 2023 Portfolio in Review

As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
  • David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • David Shaw opened 575 new positions and closed 527 in Q4 2023.
  • David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.